Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 4 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Preclinical specificity and activity of a fully human 4-1BB expressing anti-CD19 CART therapy for treatment-resistant autoimmune disease
Binghao J. Peng,Andrea Alvarado, Hangameh Cassim, Soprina Guarneri, Steven Wong, Jonathan Willis, Julia SantaMaria, Ashley Martynchuk, Victoria Stratton,Darshil Patel, Chien-Chung Chen, Yan Li,
Molecular Therapy - Methods & Clinical Developmentpp.101267, (2024)
Cited0Views0Bibtex
0
0
Preclinical specificity & activity of a fully human 41BB-expressing anti-CD19 CART- therapy for treatment-resistant autoimmune disease
Binghao J Peng,Andrea Alvarado, Hangameh Cassim, Soprina Guarneri, Steven Wong, Jonathan Willis, Julia SantaMaria, Ashley Martynchuk, Victoria Stratton,Darshil Patel, Chien-Chung Chen, Yan Li,
Molecular therapy. Methods & clinical developmentno. 2 (2024): 101267-101267
Cited0Views0WOSBibtex
0
0
Preclinical Specificity and Activity of CABA-201, a Fully Human 41BB Containing CD19 CAR T Therapy for Treatment-Resistant Autoimmune Disease
Binghao J. Peng,Andrea Alvarado, Hangameh Cassim, Ebony Cottman-Thomas, Soprina Guarneri, Ashley Martynchuk, Erica Devitt, Ivan Martinez, Jimmy Perry, Victoria Stratton, Vicky Li, Jonathan Willis,
MOLECULAR THERAPYno. 4 (2023): 669-669
Cited0Views0Bibtex
0
0
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn